Atria Wealth Solutions Inc. Has $1.15 Million Stock Holdings in VanEck Pharmaceutical ETF (NASDAQ:PPH)

Atria Wealth Solutions Inc. boosted its stake in VanEck Pharmaceutical ETF (NASDAQ:PPHFree Report) by 336.0% during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The firm owned 14,388 shares of the company’s stock after acquiring an additional 11,088 shares during the period. Atria Wealth Solutions Inc.’s holdings in VanEck Pharmaceutical ETF were worth $1,149,000 as of its most recent filing with the SEC.

Several other hedge funds have also added to or reduced their stakes in the stock. Northwestern Mutual Wealth Management Co. bought a new stake in shares of VanEck Pharmaceutical ETF in the fourth quarter valued at approximately $34,000. JPMorgan Chase & Co. bought a new stake in shares of VanEck Pharmaceutical ETF in the fourth quarter valued at approximately $46,000. Citigroup Inc. raised its position in shares of VanEck Pharmaceutical ETF by 554.0% in the fourth quarter. Citigroup Inc. now owns 1,308 shares of the company’s stock valued at $102,000 after purchasing an additional 1,108 shares during the period. Meitav Investment House Ltd. bought a new stake in shares of VanEck Pharmaceutical ETF in the second quarter valued at approximately $106,000. Finally, Cetera Advisor Networks LLC bought a new stake in shares of VanEck Pharmaceutical ETF in the fourth quarter valued at approximately $210,000.

VanEck Pharmaceutical ETF Stock Up 0.1 %

NASDAQ PPH opened at $87.38 on Tuesday. The company’s 50 day moving average is $83.12 and its 200-day moving average is $80.91. The firm has a market cap of $453.50 million, a P/E ratio of 16.59 and a beta of 0.72. VanEck Pharmaceutical ETF has a 12-month low of $73.40 and a 12-month high of $88.13.

VanEck Pharmaceutical ETF Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, December 29th. Investors of record on Thursday, December 28th were paid a dividend of $0.3074 per share. The ex-dividend date was Wednesday, December 27th. This represents a $1.23 annualized dividend and a yield of 1.41%.

VanEck Pharmaceutical ETF Company Profile

(Free Report)

The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.

Featured Articles

Want to see what other hedge funds are holding PPH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for VanEck Pharmaceutical ETF (NASDAQ:PPHFree Report).

Institutional Ownership by Quarter for VanEck Pharmaceutical ETF (NASDAQ:PPH)

Receive News & Ratings for VanEck Pharmaceutical ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VanEck Pharmaceutical ETF and related companies with MarketBeat.com's FREE daily email newsletter.